Bromodomain and Extra-Terminal Protein (BET) Inhibitor

Overview

BET Inhibitors work by blocking chemicals that tell cancer cells to grow.

Explore Tags

Myeloma Treatments

The following is a listing of myeloma treatments associated with this tag.

All Treatments

View all treatments in development for myeloma patients around the US.

Verified RO6870810
RO6870810

RO6870810 is a BET inhibitor that is openly enrolling in a dose expansion clinical trial around the US.

SparkCures Verified Accurate, up-to-date information. Learn more


Early Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified RO6870810
RO6870810

RO6870810 is a BET inhibitor that is openly enrolling in a dose expansion clinical trial around the US.

SparkCures Verified Accurate, up-to-date information. Learn more


Myeloma Clinical Trials

The following is a listing of myeloma clinical trials associated with this tag.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this tag.